Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aileron Therapeutics, Inc. - Common Stock (NQ:ALRN)

2.110 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.110
Bid (Size) 2.000 (2)
Ask (Size) 2.700 (31)
Prev. Close 2.110
Today's Range 2.110 - 2.110
52wk Range 1.610 - 7.420
Shares Outstanding 4,541,167
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to enhance lung function in IPF patients. 
Via Benzinga
ALRN Stock Earnings: Aileron Therapeutics Misses EPS for Q2 2024
ALRN stock results show that Aileron Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-6.2%
-6.2%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-41.6%
-41.6%
1 Year
-50.4%
-50.4%

More News

Read More
ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q1 2024
Via InvestorPlace
Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Aileron Therapeutics to Present at Two Upcoming Investor Conferences
From Aileron Therapeutics, Inc.
Via GlobeNewswire
BioMedNewsBreaks — Aileron Therapeutics Inc. (NASDAQ: ALRN) Closes Underwritten Registered Direct Offering
Via Investor Brand Network
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
From Aileron Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Aileron Therapeutics Inc. (NASDAQ: ALRN) Leading the Way in Thursday Trading Based on Percentage Gain
Via Investor Brand Network
ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q4 2023
Via InvestorPlace
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Aileron Therapeutics Announces CEO Transition
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024
From Aileron Therapeutics, Inc.
Via GlobeNewswire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Aileron Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aileron Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aileron Therapeutics, Inc. - Common Stock trade on?
Aileron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aileron Therapeutics, Inc. - Common Stock?
The ticker symbol for Aileron Therapeutics, Inc. - Common Stock is ALRN on the Nasdaq Stock Market
What is the current price of Aileron Therapeutics, Inc. - Common Stock?
The current price of Aileron Therapeutics, Inc. - Common Stock is 2.110
When was Aileron Therapeutics, Inc. - Common Stock last traded?
The last trade of Aileron Therapeutics, Inc. - Common Stock was at 01/10/25 04:00 PM ET
What is the market capitalization of Aileron Therapeutics, Inc. - Common Stock?
The market capitalization of Aileron Therapeutics, Inc. - Common Stock is 9.58M
How many shares of Aileron Therapeutics, Inc. - Common Stock are outstanding?
Aileron Therapeutics, Inc. - Common Stock has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.